AAAAAA
Results:
1-19
|
Results: 19
Authors:
Sabin, CA
Fisher, M
Churchill, D
Pozniak, A
Hay, P
Easterbrook, P
Williams, I
Citation: Ca. Sabin et al., Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine, J ACQ IMM D, 26(5), 2001, pp. 462-465
Authors:
Soni, N
Pozniak, A
Citation: N. Soni et A. Pozniak, Continuing HIV therapy in the ICU, CRIT CARE, 5(5), 2001, pp. 247-248
Authors:
Pozniak, A
Citation: A. Pozniak, www.safer-sex.com, CURR OPIN I, 14(1), 2001, pp. 39-40
Authors:
Torti, C
Pozniak, A
Nelson, M
Hertogs, K
Gazzard, BG
Citation: C. Torti et al., Distribution of K103N and/or Y181CHIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors, J ANTIMICRO, 48(1), 2001, pp. 113-116
Authors:
Prachalias, AA
Pozniak, A
Taylor, C
Srinivasan, P
Muiesan, P
Wendon, J
Cramp, M
Williams, R
O'Grady, J
Rela, M
Heaton, ND
Citation: Aa. Prachalias et al., Liver transplantation in adults coinfected with HIV, TRANSPLANT, 72(10), 2001, pp. 1684-1688
Authors:
Donaghy, H
Pozniak, A
Gazzard, B
Qazi, N
Gilmour, J
Gotch, F
Patterson, S
Citation: H. Donaghy et al., Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load, BLOOD, 98(8), 2001, pp. 2574-2576
Authors:
Moyle, G
Pozniak, A
Opravil, M
Clumeck, N
DelFraissy, JF
Johnson, M
Pelgrom, J
Reynes, J
Vittecoq, D
DeLora, P
Salgo, M
Duff, F
Citation: G. Moyle et al., The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues, J ACQ IMM D, 23(2), 2000, pp. 128-137
Authors:
Pozniak, A
Citation: A. Pozniak, HIV-associated tuberculosis in the era of HAART, INT J TUBE, 4(11), 2000, pp. 993-994
Authors:
Campbell, I
Drobniewski, F
Novelli, V
Ormerod, P
Pozniak, A
Citation: I. Campbell et al., Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999, THORAX, 55(3), 2000, pp. 210-218
Authors:
Ormerod, P
Skinner, C
Moore-Gillon, J
Davies, P
Connolly, M
Watson, J
Pozniak, A
Gelletlie, R
Cockcroft, A
Drobniewski, F
Leese, J
Citation: P. Ormerod et al., Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000, THORAX, 55(11), 2000, pp. 887-901
Authors:
Beck, EJ
Pozniak, A
Molesworth, A
Power, A
Griffin, J
Easterbrook, P
Fisher, M
Innes, J
Kinghorn, G
Mandel, B
Tang, A
Tomlinson, D
Williams, I
Barlow, D
Beck, EJ
Beecham, J
Bloch, R
Carrier, J
Conlon, C
Crane, P
Dalziel, M
Easterbrook, P
Fisher, M
Gray, A
Innes, J
Johnson, M
Kinghorn, G
Mandel, B
McGee, A
Mortimer, J
Ong, E
Pozniak, A
Tang, A
Tomlinson, D
Tolly, K
Williams, I
Citation: Ej. Beck et al., Changing cost of English HIV service provision 1996-1997, INT J STD A, 10(6), 1999, pp. 357-362
Authors:
Beck, EJ
Griffith, R
Fitzpatrick, R
Mandalia, S
Carrier, J
Conlon, C
Mandel, B
Ong, E
Pozniak, A
Tang, A
Tomlinson, D
Williams, I
Citation: Ej. Beck et al., Patient satisfaction with HIV service provision in NPMS hospitals: the development of a standard satisfaction questionnaire, AIDS CARE, 11(3), 1999, pp. 331-343
Authors:
Pozniak, A
Citation: A. Pozniak, Sexually transmitted diseases and urinary tract infections, CURR OPIN I, 12(1), 1999, pp. 33-34
Authors:
Beck, EJ
Mandalia, S
Williams, I
Power, A
Newson, R
Molesworth, A
Barlow, D
Easterbrook, P
Fisher, M
Innes, J
Kinghorn, G
Mandel, B
Pozniak, A
Tang, A
Tomlinson, D
Citation: Ej. Beck et al., Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997, AIDS, 13(15), 1999, pp. 2157-2164
Authors:
Del Amo, J
Malin, AS
Pozniak, A
De Cock, KM
Citation: J. Del Amo et al., Does tuberculosis accelerate the progression of HIV disease? Evidence frombasic science and epidemiology, AIDS, 13(10), 1999, pp. 1151-1158
Authors:
Babiker, A
Darbyshire, JH
Gill, ON
Johnson, AM
Phillips, AN
Porter, K
Beral, V
Brettle, R
Carne, C
Gilson, RJC
Goldberg, D
Hawkins, DA
Jeffries, D
Johnson, MA
McMichael, AJ
Mortimer, PP
Pozniak, A
Weber, J
Wellsteed, S
Citation: A. Babiker et al., How soon after HIV seroconversion is antiretroviral therapy initiated?, AIDS, 13(10), 1999, pp. 1241-1247
Authors:
Pozniak, A
Bull, T
Citation: A. Pozniak et T. Bull, Recently recognized mycobacteria of clinical significance, J INFECTION, 38(3), 1999, pp. 157-161
Authors:
Gill, JK
Greene, L
Miller, R
Pozniak, A
Cartledge, J
Fisher, M
Nelson, MR
Soni, N
Citation: Jk. Gill et al., ICU admission in patients infected with the human immunodeficiency virus -a multicentre survey, ANAESTHESIA, 54(8), 1999, pp. 727-732
Authors:
Beck, EJ
Tolley, K
Power, A
Mandalia, S
Rutter, P
Izumi, J
Beecham, J
Gray, A
Barlow, D
Easterbrook, P
Fisher, M
Innes, J
Kinghorn, G
Mandel, B
Pozniak, A
Tang, A
Tomlinson, D
Williams, I
Citation: Ej. Beck et al., The use and cost of HIV service provision in England in 1996, PHARMACOECO, 14(6), 1998, pp. 639-652
Risultati:
1-19
|